144 related articles for article (PubMed ID: 341246)
21. [Radiation and concomitant chemotherapy after surgery for breast cancer].
Calais G
Cancer Radiother; 2004 Feb; 8(1):39-47. PubMed ID: 15093200
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma.
Bang SM; Heo DS; Lee KH; Byun JH; Chang HM; Noh DY; Choe KJ; Bang YJ; Kim SR; Kim NK
Cancer; 2000 Dec; 89(12):2521-6. PubMed ID: 11135211
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis of adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy in postmenopausal women with estrogen receptor-positive, node-positive breast cancer.
Hartman AR; Fleming GF; Dillon JJ
Clin Breast Cancer; 2001 Jul; 2(2):138-43; discussion 144. PubMed ID: 11899785
[TBL] [Abstract][Full Text] [Related]
25. A randomized trial of postoperative five-versus three-drug chemotherapy after mastectomy: a Cancer and Leukemia Group B (CALGB) study.
Weiss RB; Tormey DC; Holland F; Weinberg VE; Lesnick G; Perloff M; Falkson G; Glidewell OJ
Recent Results Cancer Res; 1982; 80():170-6. PubMed ID: 7036280
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy of advanced breast cancer: a controlled randomized trial of cyclophosphamide versus a four-drug combination.
Rubens RD; Knight RK; Hayward JL
Br J Cancer; 1975 Dec; 32(6):730-6. PubMed ID: 766800
[TBL] [Abstract][Full Text] [Related]
27. Grand Rounds: Adjuvant therapy of breast cancer.
Va Med; 1977 Oct; 104(10):709-15. PubMed ID: 919723
[No Abstract] [Full Text] [Related]
28. Benefits of axillary radiotherapy unclear in women with early stage breast cancer undergoing conservative breast surgery without axillary dissection.
Sanuki-Fujimoto N
Cancer Treat Rev; 2005 Oct; 31(6):496-500. PubMed ID: 16199127
[No Abstract] [Full Text] [Related]
29. [Adjuvant chemotherapy in breast cancer].
Senn HJ
Dtsch Med Wochenschr; 1981 Nov; 106(48):1626-30. PubMed ID: 7030686
[No Abstract] [Full Text] [Related]
30. L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU).
Fisher B; Glass A; Redmond C; Fisher ER; Barton B; Such E; Carbone P; Economou S; Foster R; Frelick R; Lerner H; Levitt M; Margolese R; MacFarlane J; Plotkin D; Shibata H; Volk H
Cancer; 1977 Jun; 39(6 Suppl):2883-903. PubMed ID: 194679
[No Abstract] [Full Text] [Related]
31. A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma.
Bellon JR; Shulman LN; Come SE; Li X; Gelman RS; Silver BJ; Harris JR; Recht A
Cancer; 2004 Apr; 100(7):1358-64. PubMed ID: 15042668
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant chemotherapy with four drugs for stage 2 breast cancer.
Wheeler TK; Edelstyn GA; Bates TS; Brinkley D; Evans RG; Kitchen G; MacRae KD; Nicol NT; Spittle M; Wheeler TK
Eur J Cancer (1965); 1980; Suppl 1():161-3. PubMed ID: 7032926
[No Abstract] [Full Text] [Related]
33. [Ancillary chemotherapy with trofosfamid, methotrexate and fluoro-uracil in cancer of the breast (author's transl)].
Albrecht M; Jepsen G; Trams G; Thomsen K
Geburtshilfe Frauenheilkd; 1981 Jan; 41(1):1-5. PubMed ID: 7202984
[TBL] [Abstract][Full Text] [Related]
34. [CMF (cyclophosphamide, methotrexate, ftorafur) chemotherapy in advanced breast cancer].
Gottwald G; Szakolczai I
Orv Hetil; 1983 Jan; 124(2):79-84. PubMed ID: 6687491
[No Abstract] [Full Text] [Related]
35. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
Mouridsen HT; Palshof T
Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
[No Abstract] [Full Text] [Related]
36. [Combination chemotherapy in advanced carcinoma of the breast].
Carmo-Pereira J; Galvão-Teles A; Oliveira Costa F; Bak Gordon R; Henriques E; Dória JM; Freire Cruz M; Silveira Botelho L
Arq Patol; 1974; 46(2-3):309-23. PubMed ID: 4458643
[No Abstract] [Full Text] [Related]
37. Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study.
Jonat W; Kaufmann M; Sauerbrei W; Blamey R; Cuzick J; Namer M; Fogelman I; de Haes JC; de Matteis A; Stewart A; Eiermann W; Szakolczai I; Palmer M; Schumacher M; Geberth M; Lisboa B;
J Clin Oncol; 2002 Dec; 20(24):4628-35. PubMed ID: 12488406
[TBL] [Abstract][Full Text] [Related]
38. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
Lee JM; Abeloff MD; Lenhard RE; Baker RR
Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
[No Abstract] [Full Text] [Related]
39. Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancer.
Livi L; Saieva C; Borghesi S; De Luca Cardillo C; Scotti V; Mangoni M; Greto D; Cataliotti L; Paiar F; Bianchi S; Biti GP
J Chemother; 2009 Nov; 21(5):558-65. PubMed ID: 19933048
[TBL] [Abstract][Full Text] [Related]
40. CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.
Mouridsen HT; Palshof T; Engelsman E; Sylvester R
Eur J Cancer (1965); 1980; Suppl 1():119-23. PubMed ID: 7032921
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
